Capsovision To Release Third Quarter 2026 Financial Results On November 12, 2026

(MENAFN- GlobeNewsWire - Nasdaq) SARATOGA, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the Company will release third quarter 2026 financial results on Thursday, November 12, 2026, after the close of market. CapsoVision will host a corresponding conference call and a live webcast at 1:30 pm PT / 4:30 pm ET on the same day to discuss the results and provide a corporate update.

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 or (646) 307-1963 and referencing conference ID 2841803. The live and archived webcast of the conference call can be found on the Events page in the Investor Relations section of CapsoVision's website.

About CapsoVision

CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and screening of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video review. The Company's next pipeline product, CapsoCam ColonTM with enhanced AI, is designed to enable non-invasive colon imaging and polyp detection. With a proprietary platform targeted to expand across multiple GI indications, including esophageal and pancreatic disorders, CapsoVision is advancing a new era in capsule-based diagnostics. For more information on CapsoVision, please visit .

Investor Relations Contact
Leigh Salvo
New Street Investor Relations
...

Media Contact
Leslie Strickler and Paul Spicer
Être Communications
... | (804) 240-0807
... | (804) 503-9231

MENAFN29102026004107003653ID1111887437